Clinical Trial Update: Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports results from Phase 2 and Phase 3 studies evaluating how quickly Bepotastine Besilate ophthalmic solution relieves symptoms an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• Bepotastine Besilate Ophthalmic Solution (bepotastine besilate)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Conjunctivitis, Allergic | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2012-03-26